• Markets
    • icon
  • Companies
IDX · ASX

Integral Diagnostics Ltd (ASX:IDX)

AU$1.71

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
Volume Spike Recent Price downgrade HALO Small HALO Ords GROWTH AUS +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IDX Overview

IDX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About IDX

Website

Integral Diagnostics Ltd

Telephone

61.3.5339.0704

Address

Level 9 Suite 9.02 45 William Street Melbourne, Victoria (VIC) 3000

Description

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. It operates under three core brands: Lake Imaging, South Coast Radiology, and Global Diagnostics. The company was founded on April 29, 2008 and is headquartered in North Melbourne, Australia.

IDX Price Chart

Key Stats

Market Cap

AU$414.41M

PE

35.90

EV/EBITDA

10.9

Dividends Overview

DIV Yield

1.9%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.64 - 3.54

Trade Value (12mth)

AU$314,981.00

1 week

-0.58%

1 month

-35.47%

YTD

-42.23%

1 year

-36.9%

All time high

5.47376

Key Fundamentals

EPS 3 yr Growth

-12.200%

EBITDA Margin

19.00%

Operating Cashflow

$71m

Free Cash Flow Return

10.30%

ROIC

3.60%

Interest Coverage

4.60

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

236m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

2.78

IDX Announcements

Latest Announcements

Date Announcements

31 January 22

Becoming a substantial holder

×

Becoming a substantial holder

31 August 22

Change of Director's Interest Notice - Jacqueline Milne

×

Change of Director's Interest Notice - Jacqueline Milne

31 August 22

Release from Escrow

×

Release from Escrow

30 September 21

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 October 23

4DX: 4DMedical enters contract with Integral Diagnostics

×

4DX: 4DMedical enters contract with Integral Diagnostics

30 October 20

Chairman's Address and CEO/MD Presentation to Shareholders

×

Chairman's Address and CEO/MD Presentation to Shareholders

30 October 20

Results of Annual General Meeting

×

Results of Annual General Meeting

30 November 23

Final Director's Interest Notice - Helen Kurincic

×

Final Director's Interest Notice - Helen Kurincic

30 November 23

Notification regarding unquoted securities - IDX

×

Notification regarding unquoted securities - IDX

30 August 23

Initial Director's Interest Notice - Ingrid Player

×

Initial Director's Interest Notice - Ingrid Player

30 April 19

Presentation to Macquarie Equities Conference

×

Presentation to Macquarie Equities Conference

29 September 22

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 November 23

AGM Address and Presentation by Chair and CEO

×

AGM Address and Presentation by Chair and CEO

29 November 23

Becoming a substantial holder

×

Becoming a substantial holder

29 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

29 November 17

CAJ: Presentation - Capitol's Offer for Integral Diagnostics

×

CAJ: Presentation - Capitol's Offer for Integral Diagnostics

29 June 22

Appendix 3B

×

Appendix 3B

29 June 22

Appendix 2A

×

Appendix 2A

29 June 22

Application for quotation of securities - IDX

×

Application for quotation of securities - IDX

29 July 20

2020 Annual General Meeting

×

2020 Annual General Meeting

29 December 21

Appointment of Chief Financial Officer

×

Appointment of Chief Financial Officer

29 August 23

Notification of cessation of securities - IDX

×

Notification of cessation of securities - IDX

29 August 23

Change of Director's Interest Notice - Ian Kadish

×

Change of Director's Interest Notice - Ian Kadish

29 August 22

Appendix 4E and Annual Report to shareholders

×

Appendix 4E and Annual Report to shareholders

29 August 22

Dividend/Distribution - IDX

×

Dividend/Distribution - IDX

29 August 22

FY22 Results Announcement

×

FY22 Results Announcement

29 August 22

FY22 Investor Presentation

×

FY22 Investor Presentation

29 August 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

IDX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.16 0.07 0.11 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.15 0.07 0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.1 -55.2 54.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 27.4 22.5 35.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 13.1 10.1 10.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.33 0.21 0.25 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.15 -0.05 0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock 30.8 -35.2 16.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock 3.0 -1.8 1.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.12 0.07 0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.6 -43.2 -14.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.0 3.0 1.9 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 79 100 56 Lock Lock Lock
BPS $ Lock Lock Lock Lock 1.26 1.52 1.60 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.45 -0.15 -0.44 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.7 67.5 -200.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 203 212 236 Lock Lock Lock
Basic m Lock Lock Lock Lock 201 209 233 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 349 359 440 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.3 2.8 22.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 44 48 58 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 92 84 98 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.9 -9.1 16.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 26.4 23.4 22.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 74 77 78 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 83 75 84 Lock Lock Lock
     Growth % Lock Lock Lock Lock 29.2 -9.2 11.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 23.7 20.9 19.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 35 37 43 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 48 38 40 Lock Lock Lock
     Growth % Lock Lock Lock Lock 24.7 -19.7 4.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 13.7 10.7 9.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 45 23 31 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 14 8 6 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 31 15 25 Lock Lock Lock
     Growth % Lock Lock Lock Lock 35.8 -53.3 71.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.0 4.1 5.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 70 37 71 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 20 28 44 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -57 -56 -129 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -8 81 -32 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 49 9 27 Lock Lock Lock
     Growth % Lock Lock Lock Lock 73.8 -81.1 193.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 26 31 35 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 62 123 34 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 655 783 839 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 291 324 348 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 246 218 331 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 400 436 466 Lock Lock Lock
Equity $m Lock Lock Lock Lock 255 347 373 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 546 671 721 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.0 22.9 7.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 4.8 1.9 3.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 12.3 4.2 6.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 9.0 6.1 5.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 6.1 2.4 3.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 13.5 6.1 10.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 9.4 7.2 4.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.0 2.9 4.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 96.6 62.7 88.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.1 2.0 0.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.1 1.9 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 72.0 77.9 49.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 88.7 46.0 85.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 23.0 17.9 18.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 267.9 252.4 220.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 44.0 4.6 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 1.4 2.4 2.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.5 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.5 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 13.0 6.3 7.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 6.9 2.9 3.7 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 30.9 35.0 18.1 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 4.8 1.9 3.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.6 2.3 2.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 12.3 4.2 6.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 20.9 -0.3 44.2 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 2.6 -0.0 3.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 1.4 1.4 1.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 15.8 20.4 20.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 17.2 21.9 21.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 6.6 8.9 10.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 10.6 13.0 11.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

1.9%

Franking Level

100%

DPSg

-14.29%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

2.78%

Value ($M)

11

Prior Change

-0.30%

7 Day Change

-0.20%

1 Month Change

-0.10%

3 Month Change

-0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IDX Shortsell

Frequently Asked Questions

The current share price of Integral Diagnostics Ltd (IDX:ASX) is AU$1.71.
The 52-week high share price for Integral Diagnostics Ltd (IDX:ASX) is AU$3.54.
The 52-week low share price for Integral Diagnostics Ltd (IDX:ASX)? is AU$1.64.
The current TTM dividend payout for Integral Diagnostics Ltd (IDX:ASX) is 1.90.
The last dividend payment of Integral Diagnostics Ltd (IDX:ASX) is AU$0.04.
Integral Diagnostics Ltd (IDX:ASX) has a franking level of 100%.
Integral Diagnostics Ltd (IDX:ASX) is classified in the Healthcare.
The current P/E ratio for Integral Diagnostics Ltd (IDX:ASX) is 35.90.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.